Eye Examination Technology
SPRING Vision is developing a technology for noninvasive, real-time, multispectral retinal imaging for automated diagnostics of ocular and systemic diseases. The technology allows physicians to better differentiate between healthy and early-stage diseased retinal blood vessels. In addition to large and small retinal and choroidal blood vessel detection, an additional novel technology is evaluated for portraying a retinal oxygenation map. Coupled with AI, the above capabilities are likely to transform the practice of modern-day medicine. Microangiography, combined with retinal tissue oximetry (under clinical investigation), is expected to revolutionize the diagnostic ability and clinical application of retinal imaging, leading to a better forecast of retinal and systemic diseases through retinal imaging. The iCapture45 is a non-mydriatic and mydriatic multispectral retinal imager with a 45 degree field of view that uses SPRING Visions proprietary technology. SPRING Vision is working on the upcoming iCapture75, a mydriatic imager with a larger field of view.
| Name | SPRING Vision |
|---|---|
| Slug | spring-biomed-vision |
| Former names | Raven |
| Type / kind | startup |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoOHT5dgLDA |
| Status | inactive |
|---|---|
| Status reason | Non Active, Nov 2025 ceased to operate |
| Last update | 2026-05-17 |
| HQ country code | IL |
|---|---|
| HQ region/district | North District |
| HQ city | Haifa |
| HQ address | HaNevi'im Street 8, Haifa, Israel |
| https://www.linkedin.com/company/69188561 |
| Total raised | — |
|---|---|
| Current stage | Pre-Funding |
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}